对MASP1的综合性泛癌分析以及对瘤免疫微环境的潜在临床影响

Hongjun Yu1, Chaoqun Wang2, Shanjia Ke1

  • 1Key Laboratory of Hepatosplenic Surgery, Ministry of Education, Department of Minimally Invasive Hepatic Surgery, the First Affiliated Hospital of Harbin Medical University, Harbin, China.

概括

曼诺斯结合性莱克相关血清蛋白酶1 (MASP1) 在癌症中显著失调,影响患者的预后. MASP1影响瘤免疫微环境,并显示出作为生物标记物的潜力,特别是在肝癌中.